Calcitriol Capsule shortage
To Be Discontinued 2 presentations · 1 manufacturers · first FDA posting 2025-12-04 · last update 2025-12-04
Manufacturers: Teva Pharmaceuticals USA, Inc.
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Calcitriol, Capsule, .25 ug (NDC 0093-7352-01) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug | Posted 12/04/2025 Updated 12/04/2025 Discontinued 12/04/2025 |
| Calcitriol, Capsule, .5 ug (NDC 0093-7353-01) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug | Posted 12/04/2025 Updated 12/04/2025 Discontinued 12/04/2025 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)